All data are based on the daily closing price as of October 29, 2025
s

Shinpoong Pharm

019170.KO
9.78 USD
-1.14
-10.44%

Overview

Last close
9.78 usd
Market cap
481.71M usd
52 week high
14.06 usd
52 week low
4.50 usd
Target price
4.03 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
3.1017
Price/Book Value
2.6645
Enterprise Value
473.20M usd
EV/Revenue
3.0125
EV/EBITDA
131.4

Key financials

Revenue TTM
157.08M usd
Gross Profit TTM
63.20M usd
EBITDA TTM
1.72M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
249.46M usd
Net debt
8.99M usd

About

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.
  • Symbol
    019170.KO
  • Exchange
    KO
  • Isin
    KR7019170000
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Seoul
  • Web site
    https://shinpoong.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top